NSTL国家科技图书文献中心

1. Update on B-cell maturation antigen-directed therapies in AL amyloidosis NSTL国家科技图书文献中心

Jamroziak, Krzysztof | Zielonka, Klaudia ... - 《British Journal of Haematology》 - 2025,206(3) - 817～831 - 共15页

摘要：Systemic light chain (AL) amyloidosis* is a* | responses. However, AL amyloidosis* remains incurable, and* | cells in multiple myeloma (MM) and AL amyloidosis | target in AL amyloidosis. This review aims to provide | of anti-BCMA therapy in AL amyloidosis.

关键词： AL amyloidosis | BCMA | belantamab mafodotin

2. A Pilot Study Assessing the Accuracy of AI ChatGPT Responses for AL Amyloidosis NSTL国家科技图书文献中心

Ludovic Saba | Raymond Comenzo ... - 《European Journal of Haematology》 - 2025,114(3) - 495～499 - 共5页

摘要：ABSTRACT AL amyloidosis* is a rare, complex and* | accuracy of AI ChatGPT responses for AL amyloidosis | 82% in answering AL amyloidosis‐related questions | often challenging disease for both patients and | healthcare providers. The availability of accurate medical

关键词： AL amyloidosis | artificial intelligence | ChatGPT | hematology | oncology

3. Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis NSTL国家科技图书文献中心

Margaret Stalker | Alfred Garfall ... - 《European Journal of Haematology》 - 2025,114(3) - 443～447 - 共5页

摘要： efficacy of teclistamab in patients with AL amyloidosis | AL amyloidosis. | patients with biopsy‐proven relapsed/refractory AL | amyloidosis who were treated with teclistamab from December | ABSTRACT Introduction Teclistamab has

关键词： AL amyloidosis | bispecific antibody | safety and efficacy | teclistamab

4. Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease NSTL国家科技图书文献中心

Sheehan, Kate | Jeon, Hyesoo ... - 《The protein journal》 - 2025,44(1) - 1～20 - 共20页

摘要： amyloid light chain (AL) amyloidosis* which is* | been applied to AL amyloidosis* patients by depleting* | systemic plasma cell cytotoxicity. Amyloid fibrils in AL | amyloidosis management. We envision that this area of | Due to the large size and rapid growth of the

关键词： Antibody | Aggregation | Protein misfolding | Monoclonal antibody | Excipient | AL amyloidosis

5. Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis NSTL国家科技图书文献中心

Khwaja, Jahanzaib | Ravichandran, Sriram ... - 《British Journal of Haematology》 - 2025,206(4) - 1141～1148 - 共8页

摘要：Systemic light chain (AL) amyloidosis* is an* | treatment in AL amyloidosis. We report the UK experience | for the first-line treatment of AL amyloidosis | . Consecutive patients with a new diagnosis of systemic AL | the UK National Amyloidosis* Centre database. One*

关键词： amyloidosis | chemotherapy | immunotherapy

6. Identifying gene expression and cellular pathways involved in glomerular AL-amyloidosis and correlation with experimental data: seeking novel therapeutic interventions NSTL国家科技图书文献中心

Herrera, Guillermo A... | Teng, Jiamin ... - 《Ultrastructural pathology》 - 2025,49(2) - 216～234 - 共19页

摘要： amyloidosis were interrogated using spatial transcriptomics | amyloidosis, uncovering novel genes and new therapeutic | The prognosis of myeloma is based on | controlling the plasma cell burden and thus, management of | the production of monoclonal light chains has

关键词： AL-amyloidosis | cellular pathways | endocytosis | gene expression | HSP90AB1 | HSPB1 | kidney | lysosomes | mesangial cells | monoclonal light chains...

7. Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center NSTL国家科技图书文献中心

Dima, Danai | Goel, Utkarsh ... - 《Hematological oncology》 - 2025,43(3) - e70082～e70082 - 共9页

摘要：Localized light chain amyloidosis* (loc-AL) is* | evidence of systemic AL amyloidosis. We calculated local | progress to systemic AL amyloidosis. Observation and/or | deposition of misfolded AL fibrils. There are limited data | patients with loc-AL at our institution between January 1

关键词： AL amyloidosis | amyloidosis | localized AL amyloidosis | localized amyloidosis | plasma cell disorder

8. Cardiovascular magnetic resonance-derived left atrioventricular coupling index as a novel prognostic marker for light-chain amyloidosis NSTL国家科技图书文献中心

Wang, Yinqiu | Bi, Keying ... - 《International Journal of Cardiology》 - 2025,418 - 132630～132630 - 共9页

摘要：-chain (AL) amyloidosis. Methods: We prospectively | enrolled 179 patients with AL amyloidosis* who underwent* | independent prognostic value in AL amyloidosis. The LACI has | Background: Left atrioventricular coupling | index (LACI) is a novel biomarker, and the prognostic

关键词： Cardiovascular magnetic resonance imaging | Left atrioventricular coupling index | Light-chain (AL) amyloidosis | Prognosis

9. Primary systemic amyloidosis: A brief overview NSTL国家科技图书文献中心

Hughes, Michael Sang | Lentzsch, Suzanne - 《La Presse medicale》 - 2025,54(1) - 104267～104267 - 共7页

摘要： (AL) amyloidosis, is a rare lymphoproliferative | Primary systemic amyloidosis, or light chain | comprehensivesummary of the pathophysiology and manifestations of AL | amyloidosis; standard-of-care diagnosticapproach; typical | disorder in whichaberrant light-chain immunoglobulins

关键词： Primary systemic amyloidosis | Plasma cell dyscrasias | Novel therapeutics | Diagnostic testing

10. Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody NSTL国家科技图书文献中心

Bhutani, Divaya | Chakraborty, Rajshek...... - 《European Journal of Haematology》 - 2025,114(4) - 700～703 - 共4页

摘要：Monoclonal immunoglobulin deposition disease | patients with refractory monoclonal immunoglobulin | deposition disease. | (MIDD) is characterized by deposits of intact | monoclonal immunoglobulin protein, most commonly in the

摘要：Systemic light chain (AL) amyloidosis* is a* | responses. However, AL amyloidosis* remains incurable, and* | cells in multiple myeloma (MM) and AL amyloidosis | target in AL amyloidosis. This review aims to provide | of anti-BCMA therapy in AL amyloidosis.

关键词： AL amyloidosis | BCMA | belantamab mafodotin

摘要：ABSTRACT AL amyloidosis* is a rare, complex and* | accuracy of AI ChatGPT responses for AL amyloidosis | 82% in answering AL amyloidosis‐related questions | often challenging disease for both patients and | healthcare providers. The availability of accurate medical

关键词： AL amyloidosis | artificial intelligence | ChatGPT | hematology | oncology

摘要： efficacy of teclistamab in patients with AL amyloidosis | AL amyloidosis. | patients with biopsy‐proven relapsed/refractory AL | amyloidosis who were treated with teclistamab from December | ABSTRACT Introduction Teclistamab has

关键词： AL amyloidosis | bispecific antibody | safety and efficacy | teclistamab

摘要： amyloid light chain (AL) amyloidosis* which is* | been applied to AL amyloidosis* patients by depleting* | systemic plasma cell cytotoxicity. Amyloid fibrils in AL | amyloidosis management. We envision that this area of | Due to the large size and rapid growth of the

关键词： Antibody | Aggregation | Protein misfolding | Monoclonal antibody | Excipient | AL amyloidosis

摘要：Systemic light chain (AL) amyloidosis* is an* | treatment in AL amyloidosis. We report the UK experience | for the first-line treatment of AL amyloidosis | . Consecutive patients with a new diagnosis of systemic AL | the UK National Amyloidosis* Centre database. One*

关键词： amyloidosis | chemotherapy | immunotherapy

摘要： amyloidosis were interrogated using spatial transcriptomics | amyloidosis, uncovering novel genes and new therapeutic | The prognosis of myeloma is based on | controlling the plasma cell burden and thus, management of | the production of monoclonal light chains has

关键词： AL-amyloidosis | cellular pathways | endocytosis | gene expression | HSP90AB1 | HSPB1 | kidney | lysosomes | mesangial cells | monoclonal light chains...

摘要：Localized light chain amyloidosis* (loc-AL) is* | evidence of systemic AL amyloidosis. We calculated local | progress to systemic AL amyloidosis. Observation and/or | deposition of misfolded AL fibrils. There are limited data | patients with loc-AL at our institution between January 1

关键词： AL amyloidosis | amyloidosis | localized AL amyloidosis | localized amyloidosis | plasma cell disorder

摘要：-chain (AL) amyloidosis. Methods: We prospectively | enrolled 179 patients with AL amyloidosis* who underwent* | independent prognostic value in AL amyloidosis. The LACI has | Background: Left atrioventricular coupling | index (LACI) is a novel biomarker, and the prognostic

关键词： Cardiovascular magnetic resonance imaging | Left atrioventricular coupling index | Light-chain (AL) amyloidosis | Prognosis

摘要： (AL) amyloidosis, is a rare lymphoproliferative | Primary systemic amyloidosis, or light chain | comprehensivesummary of the pathophysiology and manifestations of AL | amyloidosis; standard-of-care diagnosticapproach; typical | disorder in whichaberrant light-chain immunoglobulins

关键词： Primary systemic amyloidosis | Plasma cell dyscrasias | Novel therapeutics | Diagnostic testing

摘要：Monoclonal immunoglobulin deposition disease | patients with refractory monoclonal immunoglobulin | deposition disease. | (MIDD) is characterized by deposits of intact | monoclonal immunoglobulin protein, most commonly in the

关键词： BCMA bispecific antibody | light chain deposition disease | monoclonal immunoglobulin deposition disease

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Systemic light chain (AL) amyloidosis is a | responses. However, AL amyloidosis remains incurable, and | cells in multiple myeloma (MM) and AL amyloidosis | target in AL amyloidosis. This review aims to provide | of anti-BCMA therapy in AL amyloidosis.

关键词： AL amyloidosis | BCMA | belantamab mafodotin

摘要：ABSTRACT AL amyloidosis is a rare, complex and | accuracy of AI ChatGPT responses for AL amyloidosis | 82% in answering AL amyloidosis‐related questions | often challenging disease for both patients and | healthcare providers. The availability of accurate medical

关键词： AL amyloidosis | artificial intelligence | ChatGPT | hematology | oncology

摘要： efficacy of teclistamab in patients with AL amyloidosis | AL amyloidosis. | patients with biopsy‐proven relapsed/refractory AL | amyloidosis who were treated with teclistamab from December | ABSTRACT Introduction Teclistamab has

关键词： AL amyloidosis | bispecific antibody | safety and efficacy | teclistamab

摘要： amyloid light chain (AL) amyloidosis which is | been applied to AL amyloidosis patients by depleting | systemic plasma cell cytotoxicity. Amyloid fibrils in AL | amyloidosis management. We envision that this area of | Due to the large size and rapid growth of the

关键词： Antibody | Aggregation | Protein misfolding | Monoclonal antibody | Excipient | AL amyloidosis

摘要：Systemic light chain (AL) amyloidosis is an | treatment in AL amyloidosis. We report the UK experience | for the first-line treatment of AL amyloidosis | . Consecutive patients with a new diagnosis of systemic AL | the UK National Amyloidosis Centre database. One

关键词： amyloidosis | chemotherapy | immunotherapy

摘要： amyloidosis were interrogated using spatial transcriptomics | amyloidosis, uncovering novel genes and new therapeutic | The prognosis of myeloma is based on | controlling the plasma cell burden and thus, management of | the production of monoclonal light chains has

关键词： AL-amyloidosis | cellular pathways | endocytosis | gene expression | HSP90AB1 | HSPB1 | kidney | lysosomes | mesangial cells | monoclonal light chains...

摘要：Localized light chain amyloidosis (loc-AL) is | evidence of systemic AL amyloidosis. We calculated local | progress to systemic AL amyloidosis. Observation and/or | deposition of misfolded AL fibrils. There are limited data | patients with loc-AL at our institution between January 1

关键词： AL amyloidosis | amyloidosis | localized AL amyloidosis | localized amyloidosis | plasma cell disorder

摘要：-chain (AL) amyloidosis. Methods: We prospectively | enrolled 179 patients with AL amyloidosis who underwent | independent prognostic value in AL amyloidosis. The LACI has | Background: Left atrioventricular coupling | index (LACI) is a novel biomarker, and the prognostic

关键词： Cardiovascular magnetic resonance imaging | Left atrioventricular coupling index | Light-chain (AL) amyloidosis | Prognosis

摘要： (AL) amyloidosis, is a rare lymphoproliferative | Primary systemic amyloidosis, or light chain | comprehensivesummary of the pathophysiology and manifestations of AL | amyloidosis; standard-of-care diagnosticapproach; typical | disorder in whichaberrant light-chain immunoglobulins

关键词： Primary systemic amyloidosis | Plasma cell dyscrasias | Novel therapeutics | Diagnostic testing

摘要：Monoclonal immunoglobulin deposition disease | patients with refractory monoclonal immunoglobulin | deposition disease. | (MIDD) is characterized by deposits of intact | monoclonal immunoglobulin protein, most commonly in the

关键词： BCMA bispecific antibody | light chain deposition disease | monoclonal immunoglobulin deposition disease

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Systemic light chain (AL) amyloidosis* is a* | responses. However, AL amyloidosis* remains incurable, and* | cells in multiple myeloma (MM) and AL amyloidosis | target in AL amyloidosis. This review aims to provide | of anti-BCMA therapy in AL amyloidosis.

摘要：ABSTRACT AL amyloidosis* is a rare, complex and* | accuracy of AI ChatGPT responses for AL amyloidosis | 82% in answering AL amyloidosis‐related questions | often challenging disease for both patients and | healthcare providers. The availability of accurate medical

摘要： amyloid light chain (AL) amyloidosis* which is* | been applied to AL amyloidosis* patients by depleting* | systemic plasma cell cytotoxicity. Amyloid fibrils in AL | amyloidosis management. We envision that this area of | Due to the large size and rapid growth of the

摘要：Systemic light chain (AL) amyloidosis* is an* | treatment in AL amyloidosis. We report the UK experience | for the first-line treatment of AL amyloidosis | . Consecutive patients with a new diagnosis of systemic AL | the UK National Amyloidosis* Centre database. One*

摘要：Localized light chain amyloidosis* (loc-AL) is* | evidence of systemic AL amyloidosis. We calculated local | progress to systemic AL amyloidosis. Observation and/or | deposition of misfolded AL fibrils. There are limited data | patients with loc-AL at our institution between January 1

摘要：-chain (AL) amyloidosis. Methods: We prospectively | enrolled 179 patients with AL amyloidosis* who underwent* | independent prognostic value in AL amyloidosis. The LACI has | Background: Left atrioventricular coupling | index (LACI) is a novel biomarker, and the prognostic